Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

1 results about "Schaftoside" patented technology

Schaftoside is a C-glycosyl compound that is apigenin substituted by beta-D-glucopyranosyl and an alpha-L-arabinopyranosyl moieties at positions 6 and 8 via C-glycosidic linkages. It has a role as an antinematodal drug and an antioxidant.

A pharmaceutical composition for treating chapped skin caused by tinea pedis (athlete's foot).

PendingCN122297564AIrritationSchaftoside
This invention discloses a pharmaceutical composition for treating chapped skin caused by tinea pedis and manuum. The composition comprises urea, olive leaf extract, oat alkaloids, and asiaticoside as active ingredients, combined with a hypoallergenic liquid crystal emulsion matrix consisting of shea butter, squalane, caprylic / capric triglycerides, and cetearyl glucoside. This invention utilizes urea to soften keratin and promote crack healing, while simultaneously inhibiting the irritation caused by urea through the synergistic effect of three plant-based anti-inflammatory components, and combining biomimetic oils to repair the skin's lipid barrier. This composition significantly reduces pain and itching at the chapped areas in patients with tinea pedis and manuum, promotes crack closure, and avoids the burning and irritation commonly found in traditional antifungal ointments.
Owner:JIANGSU SEMPOLL PHARMA